Meeting increasing demand for storing injectable drugs – SCHOTT plans to triple ready-to-use vial production capacity in the U.S.
As a globally trusted partner for advanced drug containment and delivery
solutions, SCHOTT is announcing plans to triple its vial production
capacity at its site in Lebanon, PA. In doing so, the international
technology company will further strengthen its business for ready-to-use
(RTU) solutions, which have emerged as an often preferred drug
containment alternative for high-value medications. “With our
investment, we are underlining our commitment to the global pharma
industry and particularly the U.S. market. Additionally, we are
enhancing our regional manufacturing footprint in Lebanon, Pennsylvania,
where we are proudly celebrating our site’s 30th anniversary,” said
Andreas Reisse, Executive Vice President of SCHOTT Pharma.
More info >> |